Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection
- PMID: 21342371
- DOI: 10.1111/j.1365-3156.2010.02665.x
Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection
Abstract
Worldwide, there are nearly 10 million new cases of active TB and 1.8 million associated deaths every year. WHO estimates that one-third of the world's population is infected with Mycobacterium tuberculosis (Mtb), forming a huge latent Mtb global reservoir. This renders the prospect of ever eliminating Mtb from the human race almost impossible. Several controversial issues regarding host-pathogen interactions and existing prevention and eradication strategies for latent Mtb infections need to be critically re-examined. In this viewpoint, widely held assumptions on Mtb latency and isoniazid monotherapy and chemoprophylaxis are challenged. We highlight the need for future research to resolve these issues and to develop evidence-based strategies for better understanding of equilibrium and escape of Mtb in the human body, eventually leading to global recommendations for elimination of the latent Mtb state through informed policy and practice. Until such strategies and policies are realized, WHO and TB experts will have to settle for global TB control rather than eradication.
© 2010 Blackwell Publishing Ltd.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.PLoS Med. 2016 Oct 25;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. eCollection 2016 Oct. PLoS Med. 2016. PMID: 27780211 Free PMC article. Review.
-
Managing TB in the 21st century: existing and novel drug therapies.Ther Adv Respir Dis. 2008 Dec;2(6):401-8. doi: 10.1177/1753465808099522. Ther Adv Respir Dis. 2008. PMID: 19124385 Review.
-
Clinical tuberculosis problems and management.Acta Med Indones. 2006 Apr-Jun;38(2):109-16. Acta Med Indones. 2006. PMID: 16799215 Review.
-
Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.Int J Infect Dis. 2010 Apr;14(4):e292-7. doi: 10.1016/j.ijid.2009.05.007. Epub 2009 Aug 4. Int J Infect Dis. 2010. PMID: 19656705
Cited by
-
Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.Int J Infect Dis. 2022 Nov;124 Suppl 1:S69-S74. doi: 10.1016/j.ijid.2022.03.012. Epub 2022 Mar 14. Int J Infect Dis. 2022. PMID: 35301102 Free PMC article. Review.
-
Tuberculosis vaccines and therapeutic drug: challenges and future directions.Mol Biomed. 2025 Jan 22;6(1):4. doi: 10.1186/s43556-024-00243-6. Mol Biomed. 2025. PMID: 39841361 Free PMC article. Review.
-
Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. eCollection 2014. Front Immunol. 2014. PMID: 24795723 Free PMC article. Review.
-
Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.Am J Respir Crit Care Med. 2020 Oct 15;202(8):1159-1168. doi: 10.1164/rccm.201908-1576OC. Am J Respir Crit Care Med. 2020. PMID: 32551948 Free PMC article.
-
Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study.PLoS One. 2012;7(6):e38816. doi: 10.1371/journal.pone.0038816. Epub 2012 Jun 18. PLoS One. 2012. PMID: 22719954 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources